The feasibility of using gold nanoparticles (AuNPs) for biomedical applications has led to considerable interest in the development of novel synthetic protocols and surface modification strategies for AuNPs to produce biocompatible molecular probes. This investigation is, to our knowledge, the first to elucidate the synthesis and characterization of sodium hexametaphosphate (HMP)-stabilized gold nanoparticles (Au-HMP) in an aqueous medium. The role of HMP, a food additive, as a polymeric stabilizing and protecting agent for AuNPs is elucidated. The surface modification of Au-HMP nanoparticles was carried out using polyethylene glycol and transferrin to produce molecular probes for possible clinical applications. In vitro cell viability studies performed using as-synthesized Au-HMP nanoparticles and their surface-modified counterparts reveal the biocompatibility of the nanoparticles. The transferrin-conjugated nanoparticles have significantly higher cellular uptake in J5 cells (liver cancer cells) than control cells (oral mucosa fibroblast cells), as determined by inductively coupled plasma mass spectrometry. This study demonstrates the possibility of using an inexpensive and non-toxic food additive, HMP, as a stabilizer in the large-scale generation of biocompatible and monodispersed AuNPs, which may have future diagnostic and therapeutic applications.
Introduction
The engineering of nanoscale materials with novel properties by controlled synthesis and assembly is important for various technological applications. In the past few years, considerable progress has been made in the synthesis of monodispersed and well-defined structured nanoparticles for specific applications [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Recently, great advances have been made in the use of metal nanoparticles, especially gold, for biomedical applications, owing to their stability, chemical reactivity, non-toxic nature and strong absorption and scattering properties [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] . The initial requirements for the use of metal nanoparticles in biomedical applications are stability, biocompatibility, non-toxicity, solubility in water and easy clearance from the body when used for in vivo studies. At nano-dimensions, achieving a stable dispersion of the particles with the above desired properties is essential for their successful integration into biological systems. This fact underlies the importance of stabilizers, used in the synthesis of nanoparticles, which not only protect particles against aggregation but also control their functional properties.
To date, a variety of stabilizers have been employed for the synthesis of AuNPs [1, 28, 30] . Most of them are toxic, and the removal of excess stabilizer causes unwanted aggregation of the particles, which is a matter of concern for various clinical applications. Hence, a biocompatible polymer is also used for modification of Au nanoparticles. Biver et al showed that two types of Au nanoparticles are synthesized using thioalkylated oligoethylene glycols and functionalized with two kinds of fluorescent Acridine Orange derivatives [31] . Wang et al used an x-ray irradiation method to produce polyethylene glycol (PEG)-stabilized Au nanoparticles [32] . Exchange of organic molecules modified on Au nanoparticles with PEG is also performed to prepare biocompatible PEGstabilized Au nanoparticles [33] . This investigation introduces sodium hexametaphosphate (NaPO 3 ) 6 (HMP), a food additive, as a stabilizer in the generation of AuNPs, facilitating synthesis in an aqueous medium.
HMP is used as a sequestering agent and has applications in a wide variety of industries, including as a food additive as well as stabilizer of various nanoparticles such as BaSO 4 [34] , ZnCdS [35] , ZnS:Cu 2+ [36] , (K, Na)NbO 3 [37] , (ZnS:Mn 2+ ) [38] and so on. The oral toxicity limit of HMP in the literature (LD50) is 3053 mg kg −1 . Available studies of the toxicity limit of HMP suggest that its use as a stabilizer in the generation of AuNPs is safe at the microgram level, and causes no undesirable side effects.
The objective of the present investigation is to demonstrate the synthesis of biocompatible AuNPs using a non-toxic stabilizer, HMP, and the surface modification of the assynthesized nanoparticles to examine their associated cell viability and to determine the utility of the surface-modified nanoparticles for potential target-specific delivery.
To ensure the ease of use of the Au-HMP nanoparticles for clinical applications, these nanoparticles were sequentially conjugated with thiolated polyethylene glycol (PEG-SH) and a transferrin (Tf) ligand. PEG-SH was employed to modify the surfaces of AuNPs owing to its biocompatible nature and strong binding with gold. When PEG-SH binds to AuNPs it disrupts the strong interparticle interaction that causes nanoparticle aggregation, allowing the particles to be dispersed in aqueous media and making them amenable to biomedical applications [23, 24, [39] [40] [41] . However, Tf is a well known ligand for conjugating drugs, and can be specifically recognized and taken up by various tumor cells that express Tf receptor (TFR1), such as J5 cells (liver cancer cells). Therefore, the Tf receptor interaction has been exploited as an efficient pathway for the cellular uptake of drugs and genes, as well as for targeting different markers that are overexpressed on cancer cells [42] [43] [44] [45] [46] [47] . In this study, an in vitro cell viability test is performed of as-synthesized HMP-stabilized AuNPs (Au-HMP), PEG-coated Au-HMP (Au-HMP-PEG) nanoparticles and Tf-coated PEG-Au-HMP (Au-HMP-PEGTf) nanoparticles using normal squamous gingival epithelial (S-G) cells and human oral cancer (SAS) cells. Finally, the uptake of Tf-conjugated nanoparticles in the J5 cells and oral mucosa fibroblast (OMF) cells is analyzed. This investigation aims to synthesize biocompatible molecular probes, which will play a significant role in the advancement of clinically useful diagnostic and therapeutic nanomedicinal products.
Experimental details

Chemicals and materials
Hydrogen tetrachloroaurate (III) hydrate, sodium hexametaphosphate (HMP) and sodium borohydrate (NaBH 4 ) were obtained from Alfa Aesar. PEG-SH with molecular weight 5000 was obtained from NOF Corporation Sunbright. Chrom Pure Human Tf was purchased from Jackson Immuno Research Laboratories, USA. All of these chemicals were used without further purification. The water used throughout this investigation was reagent-grade water, produced using a Milli-Q SP ultrapure-water purification system from Nihon Millipore Ltd, Tokyo.
Preparation of HMP-stabilized Au nanoparticles
Following a typical procedure, 0.25 ml of 0.01 M aqueous HAuCl 4 was added to 7.5 ml of 2 mM HMP solution and mixed by magnetic stirring at 250 rpm. To this solution, 0.6 ml of aqueous 0.01 M NaBH 4 was added at once. The formation of the AuNPs was observed as an instantaneous color change of the solution from pale yellow to bright red after addition of the reducing agent. The Au-HMP NPs are further purified by centrifugation several times to remove free HMP.
Surface modification of Au-HMP nanoparticles
The surface of HMP-stabilized AuNPs was modified by sequential conjugation with PEG-SH and Tf. First, 100 ml of Au-HMP NPs were mixed with 0.5 ml of 5 mM PEG-SH followed by stirring overnight to ensure proper binding. The thiolated HMP-stabilized AuNPs (Au-HMP-PEG) (5.0 ml) were further mixed with 0.2 ml of 1.0 mg ml −1 Tf solution and stirred overnight for the complete adsorption of the ligand on the surface of Au-HMP NPs. The Au-HMP-Tf NPs is also further purified by centrifugation for several times to remove free Tf.
Characterization
UV-vis absorption spectra of AuNPs were obtained using a Shimadzu spectrometer in the range of 425-700 nm. For transmission electron microscopy, nanoparticle solution was dried on a carbon film grid and imaged at 200 kV (JEM 2010, JEOL). Crystallographic structural analysis was carried out using X'Pert PRO x-ray powder diffraction (XRD) with Cu Kα radiation (λ = 1.5418Å). For Fourier transform infrared (FTIR) spectroscopy, the sample solutions were dried onto silicon wafer substrates and analyzed at wavenumbers from 3200 to 750 cm −1 using a Perkin Elmer 2000 FTIR system. The surface charge on the AuNPs before and after surface modification was determined using a MALVERN Zetasizer Nano ZS. Thermogravimetry analyses (TGA) were performed on a thermogravimetric analyzer with a TA 5100 instrument at a heating rate of 5
• C min −1 up to 500
• C in a flow of air. The uptake of metal by the cells was evaluated using a Thermo X series II inductively coupled plasma (ICP) mass spectrometer.
Cell culture and cytotoxicity assay
For the cell viability tests, a spontaneously immortalized human S-G cell line and human SAS cell line were used. They were maintained in high-glucose Dulbecco's modified Eagle's medium (DMEM), containing fetal calf serum (10%), L-glutamine (2.9 mg ml −1 ), streptomycin (1 mg ml −1 ) and penicillin (1000 units ml −1 ). Cell cytotoxicity was evaluated by the colorimetric MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide, a tetrazole] assay. Briefly, cells were plated in 96-well plate at an initial density of 2000 cells per well and treated with different concentrations of asprepared AuNPs and their surface-modified counterparts for 48 h. Next, the cells were incubated for 4 h at 37
• C in 100 μl of fresh serum-free medium that contained 0.5 mg ml −1 MTT. After the MTT solution was removed, the formazan crystals were dissolved by adding 100 μl of dimethyl sulfoxide (DMSO). The concentration of the formazan product was determined by spectrophotometry at an absorbance wavelength between 570 and 630 nm.
TFR1 expression analysis
To determine the TFR1 expression in the cells, a specific TFR1 cDNA fragment was amplified by reverse transcription polymerase chain reaction (RT-PCR). First, total RNA of each cell line was isolated by TRIzol reagent (Invitrogen). 5 μg of total RNA was used for reverse transcription with an oligo (dT) primer and reverse transcriptase (Stratagene). The 5 primer and 3 primer sequences that were used in the experiment were aaaatccggtgtaggcacag and ttaaatgcagggacgaaagg, (Mission, Taiwan), respectively. The PCR program was performed using Mastercycler (Eppendorf) for 4.5 min at 94
• C followed by 30 cycles of 30 s at 94
• C, 30 s at 60
• C and 30 s at 72 • C each. A final extension was carried out at 72
• C for 10 min. The PCR products were then mixed with loading dye and run in a 1.8% agarose gel.
Determining cellular uptake of AuNPs using ICP mass spectrometry (MS)
The cellular uptake of AuNPs was investigated in terms of the Au 3+ concentration in the cells using ICP-MS analysis. First, the J5 and OMF cells were separately incubated with Au-HMP-PEG or Au-HMP-PEG-Tf nanoparticles at 37
• C for 4 h. After conjugation of the AuNPs with cells, the suspension was removed and the cells that were attached to AuNPs were washed several times using phosphate-buffered saline; they were then treated with aqua regia for 1 h to completely dissolve the AuNPs/cells. Finally, the dissolved AuNPs/cells were diluted with ultrapure water to yield a suitable concentration for further analysis by ICP-MS.
Results and discussion
Schematic processes of Au-HMP-PEG-Tf
A simple one-step synthesis of spherical AuNPs with uniform size distribution using a non-toxic stabilizer, sodium hexametaphosphate (HMP), is demonstrated. The synthesis was carried out by reducing tetrachloroauric acid in the presence of HMP using sodium borohydride as a reducing agent. The color of the dispersion instantly changed from yellow to red when sodium borohydride was added to a solution of gold precursor in the presence of HMP, confirming the formation of AuNPs in the solution. The introduction of a stabilizer prevents the thermodynamically favored aggregation of the nanoparticles. HMP-stabilized AuNPs were found to be stable for several months without any sign of agglomeration. HMP was critical to the controlled growth of AuNPs with high yield and stabilized the suspension of AuNPs against agglomeration. Figure 1 (a) presents the surface modification strategy of these Au-HMP nanoparticles using PEG-SH and Tf. The change in the surface charge of Au-HMP nanoparticles after coverage of their surface with PEG-SH and Tf was identified by performing zeta potential analysis (table 1). The HMPstabilized AuNPs bear a negative surface charge owing to the presence of phosphate groups from HMP, which, on binding with PEG-SH, exhibited an almost neutral surface. Au-HMP nanoparticles were covalently conjugated to PEG by reaction of the thiol group of PEG-SH and the gold surface in aqueous solution, forming a chemisorbed surface layer on the gold surfaces. Further conjugation of the Au-HMP-PEG nanoparticles with Tf yielded partially negatively charged Au-HMP-PEG-Tf nanoparticles, perhaps because of the amide groups present in the glycoprotein-Tf. The results of zeta potential analyses, showing the coating of PEG-SH and Tf on the surfaces of the Au-HMP nanoparticles, were further supported by the FTIR analysis. Figure 2 shows the UV-vis spectra of HMP-stabilized AuNPs before and after conjugation with PEG-SH and Tf. For the as-prepared Au-HMP sample, the peak at 515.5 nm is a characteristic absorption peak of AuNPs in solution. The shift in the resonance peak maximum upon conjugation with PEG-SH and transferrin is small, indicating that the physical surroundings, in terms of refractive index or dielectric constant, at the interface of solution and the surface of the AuNPs, do not substantially change. However, a slight peak broadening after the coverage of the surfaces of the Au-HMP nanoparticles with PEG-SH and Tf indicates that the surface plasmon resonance absorption peak is influenced by the PEG-SH or Tf. These observations reveal that the surface-modified nanoparticles form a stable dispersion in the aqueous solution.
UV-visible spectra of modified AuNPs
Transmission electron microscopy (TEM) analysis of modified AuNPs
The TEM images of HMP-stabilized AuNPs recorded at room temperature indicate the presence of spherical nanoparticles 
FTIR investigation of synthetic processes
The surface modification of as-synthesized Au-HMP nanoparticles was analyzed by FTIR spectroscopy. Figure 5 displays IR spectra in the spectral range of 750-3000 cm −1 for Au-HMP, Au-HMP-PEG and Au-HMP-PEG-Tf. The FTIR spectrum of as-synthesized Au-HMP nanoparticles shows three absorption peaks at 1264, 1085 and 877 cm −1 , which can be assigned to HMP [48] . This suggests the stabilization of Au nanoparticles by HMP. The FTIR spectrum of PEG-coated Au-HMP nanoparticles clearly reveals bands close to 2881 and 1114 cm −1 . These bands correspond to OCH 2 and CH 2 OCH 2 stretching modes, respectively [49] , indicating coverage of the nanoparticle surface by PEG. Upon further conjugation of Au-HMP-PEG nanoparticles with Tf, an additional band at maximum of 1654 cm −1 , assigned to the amide groups in the Tf, appeared, demonstrating that the surfaces of Au-HMP-PEG nanoparticles were covered by Tf molecules [50] . Thus, FTIR measurements confirmed the successful development of Tf-conjugated Au-HMP nanoparticles.
Understanding the role of HMP in the generation of AuNPs is very important, since AuNPs synthesized in the absence of HMP were unstable in the aqueous phase, leading to agglomeration. The structure of HMP consists of six phosphate anions, which are linked to each other to form a ring-like structure, with each phosphate group linked to one sodium atom outside the ring. Given the structure of HMP, the two main factors that contribute to the stabilization of AuNPs can be reasonably believed to be the electrostatic interactions between the negatively charged phosphate groups and the metal ions in solution and/or steric hindrance that is associated with the bulky nature of HMP [48] . When a gold precursor solution is mixed with the HMP solution, the sodium ions dissociate from the HMP salt solution in the aqueous medium, facilitating electrostatic interaction between Au 3+ ions and phosphate groups from HMP. The introduction of a strong reducing agent, sodium borohydride, to the reaction system favors the formation of AuNPs, leaving the phosphate groups covered on the surface of these nanoparticles ( figure 1(b) ). Thus, the surface coverage of AuNPs with large HMP ions restricts the growth of the Au-HMP particles on the nanoscale, with a stable dispersion which prevents agglomeration. This assumption is supported by the peaks associated with HMP in the observed IR spectrum of the Au-HMP nanoparticles (figure 5).
TGA analysis of modified AuNPs
In order to further reveal the amount of organic modification, TGA was applied to analyse the weight loss. The TGA analyses of the Au-HMP, Au-HMP-PEG and Au-HMP-PEG-Tf samples are shown in figure 6 . Based on the TGA data, we calculate that the weight per cent (wt%) ratio between Au, HMP, PEG and Tf is around 62:5:2:1, respectively. The result is useful to help us to understand the relative coating ratio in the final samples.
Cytotoxicity assay using modified AuNPs
Biomedical applications involve intentional exposure to nanoparticles. Therefore, understanding the properties of nanoparticles and their effects on the human body is crucial before they are applied clinically. The cytotoxic effects and future health problems caused by nanoparticles must be considered in the engineering of such materials on the nanoscale. Few studies of the cellular uptake and cytotoxicity of AuNPs are available [30, [51] [52] [53] [54] [55] [56] [57] . Similar cell viability tests were performed in the present investigation using S-G cells as control and SAS cells to analyze the biocompatibility of the Au-HMP nanoparticles. Au-HMP, Au-HMP-PEG, and Au-HMP-PEG-Tf nanoparticles were found not to affect the cell viability of S-G and SAS cells (figure 7). The above results clearly demonstrate that the Au-HMP nanoparticles and their surface-modified counterparts exhibited no apparent cytotoxicity, even at high concentrations, reflecting their biocompatible nature and further clinical applicability.
Cell uptake for biorecognition of Au-HMP-PEG-Tf
To evaluate the targeting applicability of the Au-HMP-PEGTf nanoparticles, cellular uptake studies were performed using 
J5 liver cancer cells as target and OMF cells as control cells.
It is well known that the J5 liver cancer cells overexpress Tf receptors on the cell surface, facilitating receptor-mediated endocytosis (RME). The presence of Tf receptors on the cell surface was confirmed by RT-PCR herein. The J5 cell line exhibited a higher-intensity gel band, associated with TFR1 gene expression, than that of the OMF cell line, confirming the presence of more overexpressed Tf receptors on the surface of J5 cells than OMF cells ( figure 8(a) ). Furthermore, Au-HMP-PEG-Tf and Au-HMP-PEG nanoparticles were incubated for 4 h with OMF and J5 cells at 37
• C to observe the cellular uptake. ICP-MS analysis was then used to determine the amount of Au taken up by the cells ( figure 8(b) ). The results reveal that the amount of Au taken up by J5 cancer cells after incubating with Au-HMP-PEG-Tf nanoparticles is five-fold higher than after incubating with Au-HMP-PEG nanoparticles (P < 0.05). This significant difference is evidenced by the interaction between Au-HMP-PEG-Tf nanoparticles and Tf receptors overexpressed on the surface of J5 cancer cells. It also confirms the successful modification of Au-HMP nanoparticles with Tf. However, the uptake of a small amount of Au-HMP-PEG by J5 cells may arise from direct endocytosis by cells or unexpected physical adherence. Similarly, as expected, the control OMF cells exhibited low Au uptake because their surfaces had fewer Tf receptors than J5 cells. Therefore, the pronounced change in cellular uptake of nanoparticles upon modification by Tf reveals that the chemical surface properties of nanoparticles play a significant role in controlling the uptake of nanoparticles by cells. Tfconjugated nanoparticles have a greater affinity toward the malignant J5 cells than normal OMF cells owing to their specific interaction with a large number of Tf receptors on the cell membrane. We believe that electrostatic physisorption is the main driver of interaction between Au-HMP-PEG nanoparticles and Tf, because the PEG of Au-HMP-PEG has no effective functional group to conjugate with Tf in addition to the electrostatic interaction. Although it is unstable and pHdependent, the cell uptake experiment reveals it is effective and improved at pH value = 7.4. Hence, the above results reveal that this interaction is stable and useful at pH value = 7.4. This interaction is also facilitated by the neutral or slightly positively charged surface that is provided by thiolated PEG modification, and promotes the approach of negatively charged Tf toward the Au-PEG. Thus, this investigation demonstrates successful development of Tf-conjugated biocompatible nanoparticles, which have significant potential as biocompatible molecular probes for clinical diagnosis.
Conclusions
A novel, one-step method for generation of AuNPs with uniform size distribution using a non-toxic stabilizer, HMP, in an aqueous medium was presented for the first time. The experimental results demonstrate that the easily available food additive HMP can be successfully used as a stabilizer for the generation of biocompatible AuNPs. This work represents an initial step in the generation of nanoparticles using HMP as a stabilizer and this approach can be extended to the synthesis of different biocompatible metal nanoparticles. Further conjugation of the as-synthesized nanoparticles with transferrin ligand enhanced their uptake by liver cancer cells. The results of this study demonstrate that the tailored approach for generating biocompatible gold molecular probes is highly promising for clinical applications.
